Diagnosis and Allergen Identification of Perioperative Anaphylaxis
1 other identifier
observational
115
1 country
5
Brief Summary
Perioperative anaphylaxis may lead to fatal respiratory and/or circulatory events, yet both clinical diagnosis and management are challenging. Serum tryptase is an indicator that can provide important retrospective diagnostic value for anaphylaxis. Another key point in perioperative anaphylaxis management is to identify the allergens, and thus avoid re-exposure during later perioperative management. Skin testing is an important way to identify allergens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2025
CompletedStudy Start
First participant enrolled
January 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
November 24, 2025
November 1, 2025
2.8 years
January 20, 2025
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of severe perioperative anaphylaxis
Perioperative anaphylaxis is defined as anaphylaxis that is confirmed by clinical signs and symptoms and changes of serum tryptase level according to the World Allergy Organization Anaphylaxis Guidance 2020 and occurred in the operating room. Severe perioperative anaphylaxis indicates grade 3 or above according to the World Allergy Organization systemic allergic reaction grading system. The incidence is calculated as the number of cases with severe perioperative anaphylaxis divided by the total number of cases who undergo surgery in the operating room during the study period.
On the day of surgery in the operating room
Secondary Outcomes (3)
Diagnostic rate of anaphylaxis in patients with suspected perioperative anaphylaxis.
On the day of surgery in the operating room
Incidence of perioperative anaphylaxis
On the day of surgery in the operating room
Allergen detection in patients with perioperative anaphlaxis
At least 4-6 weeks after the confirmed perioperative anaphylaxis
Other Outcomes (3)
Rate of surgical suspension due to suspected perioperative anaphylaxis.
On the day of surgery suspected perioperative anaphylaxis
Rate of unplanned ICU admission due to suspected perioperative anaphylaxis
Within 24 hours of suspected perioperative anaphylaxis
Rate of recurrence of perioperative anaphylaxis
On the day of surgery in the operating room
Study Arms (1)
Suspected anaphylaxis
Adult patients with suspected anaphylaxis in the operating rooms, or with history of suspected anaphylaxis in the operating room.
Eligibility Criteria
Patients with suspected anaphylaxis in the operating room.
You may qualify if:
- Aged 2 years or over;
- Suspected anaphylaxis in the operating rooms, or history of suspected anaphylaxis in the operating room.
You may not qualify if:
- Refuse to participate;
- Other conditions that are considered unsuitable for study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Beijing Anorectal Hospital (Beijing Erlong Road Hospital)
Beijing, Beijing Municipality, China
Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, China
Beijing, Beijing Municipality, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
Related Publications (3)
Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, Riggioni C, de Silva D, Angier E, Arasi S, Bellou A, Beyer K, Bijlhout D, Bilo MB, Bindslev-Jensen C, Brockow K, Fernandez-Rivas M, Halken S, Jensen B, Khaleva E, Michaelis LJ, Oude Elberink HNG, Regent L, Sanchez A, Vlieg-Boerstra BJ, Roberts G; European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022 Feb;77(2):357-377. doi: 10.1111/all.15032. Epub 2021 Sep 1.
PMID: 34343358BACKGROUNDTran R, Pedersen K, Kolawole H, Roessler P, Scolaro R. Australian and New Zealand Anaesthetic Allergy Group/Australian and New Zealand College of Anaesthetists perioperative anaphylaxis management guideline 2022. Anaesth Intensive Care. 2024 May;52(3):147-158. doi: 10.1177/0310057X231215823. Epub 2024 Apr 8.
PMID: 38587791BACKGROUNDManian DV, Volcheck GW. Perioperative Anaphylaxis: Evaluation and Management. Clin Rev Allergy Immunol. 2022 Jun;62(3):383-399. doi: 10.1007/s12016-021-08874-1. Epub 2021 Jul 10.
PMID: 34247332BACKGROUND
Biospecimen
Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman of Department of Anesthesiology
Study Record Dates
First Submitted
January 20, 2025
First Posted
January 27, 2025
Study Start
January 25, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
November 24, 2025
Record last verified: 2025-11